Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2025-12-24 @ 10:55 PM
NCT ID:
NCT02342769
Eligibility Criteria:
Inclusion Criteria:
* Documented HIV infection
* Age ≥ 18 years
* HLA-B\*5701-negative
* Decision for first initiation of TRIUMEQ therapy made by the attending physician independent of the inclusion in this observational study
Exclusion Criteria:
* Prior dolutegravir therapy (cf. also Capping ABC in section 3.3 Recruitment)
* Participation in a clinical trial during this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02342769
Study Brief:
Protocol Section:
NCT02342769